Drug delivery technology
View Patent ↗The invention relates to a novel drug delivery technology. More particularly the invention relates to a method of delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient; to a throwaway or reusable device for delivering at least one therapeutic compound or a formulation comprising the at least one therapeutic compound to a patient in a manner as set out by the method; to a pioneer projectile for use in said method; to formulations for use in said method and to an injectate comprising a pioneer projectile and formulation. It also relates to a disposable component containing either a pioneer projectile or an injectate. The invention also relates to a throwaway or reusable device for delivering at least one therapeutic compound, or a formulation comprising the at least one therapeutic compound (hereafter drug) to a patient, and a method for administering a drug to a patient using said device. It also relates to a packaged drug for use with said device.
1. A water soluble, lipid soluble or otherwise biodegradable pioneer projectile, having a diameter of from about 1 mm to less than 3 mm, a height of from 1.5 mm to less than 10 mm and which is capable of penetrating the skin of a human or animal to thereby facilitate the injection of at least one following therapeutic compound or therapeutic compound containing formulation in a contained state, comprises:
a first penetrating face which in use penetrates the human or animal's skin; and
remote from the first face a second driven face which in the course of injection is the face upon which a driving force is exerted through the contained therapeutic compound or therapeutic compound containing formulation; wherein said pioneer projectile has an aspect ratio of width to height of less than a 1:3; and
wherein the skin penetrating face is blunt or gently curved.
2. A water soluble, lipid soluble or otherwise biodegradable pioneer projectile, having a diameter of less than 3 mm and which is capable of penetrating the skin of a human or animal to thereby facilitate the injection of at least one following therapeutic compound or therapeutic compound containing formulation in a contained state, comprises:
a first penetrating face which in use penetrates the human or animal's skin;
remote from the first face a second driven face which in the course of injection is the face upon which a driving force is exerted through the contained therapeutic compound or therapeutic compound containing formulation; wherein said pioneer projectile has an aspect ratio of width to height of less than 1:3; and
wherein the face for contacting the therapeutic compound or therapeutic compound containing formulation in a contained state is flat.
3. A water soluble, lipid soluble or otherwise biodegradable pioneer projectile, having a diameter of less than 3 mm and which is capable of penetrating the skin or human or animal to thereby facilitate the injection of at least one following therapeutic compound or therapeutic compound containing formulation in a contained state, comprises:
a first penetrating face which in use penetrates the human or animal's skin;
remote from the first face a second driven face which in the course of injection is the face upon which a driving force is exerted through the contained therapeutic compound or therapeutic compound containing formulation; wherein said pioneer projectile has an aspect ratio of width to height of less than 1:3; and
wherein the face for contacting the therapeutic compound or therapeutic compound containing formulation in a contained state is concave or otherwise hollowed.
4. A water soluble, lipid soluble or otherwise biodegradable pioneer projectile, having a diameter of less than 3 mm and which is capable of penetrating the skin of a human or animal to thereby facilitate the injection of at least one following therapeutic compound or therapeutic compound containing formulation in a contained state, comprises:
a first penetrating face which in use penetrates the human or animal's skin;
remote from the first face a second driven face which in the course of injection is the face upon which a driving force is exerted through the contained therapeutic compound or therapeutic compound containing formulation; wherein said pioneer projectile has an aspect ratio of width to height of less than 1:3; and
wherein a barrier material is provided over at least the face for containing the therapeutic compound in a contained state.